FRI409 Childbirth Experiences In Women With Polycystic Ovary Syndrome
Disclosure: A.E. Husby: None. M.R. Simpson: None. R. Dalbye: None. E. Vanky: None. T.S. Løvvik: None. Introduction:Polycystic ovary syndrome (PCOS) affects 5-20% of women. Women with PCOS frequently suffer from metabolic, psychological, and reproductive comorbidities. Pregnancy complications such as...
Published in: | Journal of the Endocrine Society |
---|---|
Main Authors: | , , , , |
Format: | Text |
Language: | English |
Published: |
Oxford University Press
2023
|
Subjects: | |
Online Access: | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554886/ https://doi.org/10.1210/jendso/bvad114.1602 |
id |
ftpubmed:oai:pubmedcentral.nih.gov:10554886 |
---|---|
record_format |
openpolar |
spelling |
ftpubmed:oai:pubmedcentral.nih.gov:10554886 2023-11-05T03:42:59+01:00 FRI409 Childbirth Experiences In Women With Polycystic Ovary Syndrome Husby, Anne Engtrø Simpson, Melanie Rae Dalbye, Rebecka Vanky, Eszter Løvvik, Tone Shetelig 2023-10-05 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554886/ https://doi.org/10.1210/jendso/bvad114.1602 en eng Oxford University Press http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554886/ http://dx.doi.org/10.1210/jendso/bvad114.1602 © The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com J Endocr Soc Reproductive Endocrinology Text 2023 ftpubmed https://doi.org/10.1210/jendso/bvad114.1602 2023-10-08T01:20:25Z Disclosure: A.E. Husby: None. M.R. Simpson: None. R. Dalbye: None. E. Vanky: None. T.S. Løvvik: None. Introduction:Polycystic ovary syndrome (PCOS) affects 5-20% of women. Women with PCOS frequently suffer from metabolic, psychological, and reproductive comorbidities. Pregnancy complications such as gestational diabetes, pregnancy-induced hypertension, pre-eclampsia, and preterm birth are more common in PCOS. Metformin has been used in an attempt to improve pregnancy outcomes in PCOS. Childbirth experience is influenced by previous life- and birth experiences, preparedness, fear of childbirth, experiences of pain and control, and the mode and outcome of delivery. A positive childbirth experience may result in improved post-partum functioning and bonding with the newborn. In contrast, a negative childbirth experience is associated with postnatal depression, post-traumatic stress symptoms and difficulties in relating to one’s partner and newborn. To our knowledge, there are no previous studies on women with PCOS and their childbirth experiences. The primary aim of our study is to explore childbirth experiences in women with PCOS compared to a reference population. The secondary aim is to explore whether metformin vs placebo during pregnancy affects the childbirth experiences in women with PCOS. Materials and methods:This study combines data from two RCTs. In the PregMet2 study, women with PCOS in Norway, Sweden and Iceland were randomized to metformin or placebo. Main outcomes were miscarriage and preterm delivery. The Labor Progression Study (LaPS) (reference population) in Norway, compared WHO partograph to the Zhang’s guidelines for progression of labor in women in Robson group 1*. Both studies used the Childbirth Experience Questionaire (CEQ). Total CEQ scores and scores (separately) from the four domains “own capacity”, “perceived safety”, “professional support” and “participation” were compared between a) women with PCOS in the PregMet2 study (n=131) and the reference population, the LaPS study (n=3604) and ... Text Iceland PubMed Central (PMC) Journal of the Endocrine Society 7 Supplement_1 |
institution |
Open Polar |
collection |
PubMed Central (PMC) |
op_collection_id |
ftpubmed |
language |
English |
topic |
Reproductive Endocrinology |
spellingShingle |
Reproductive Endocrinology Husby, Anne Engtrø Simpson, Melanie Rae Dalbye, Rebecka Vanky, Eszter Løvvik, Tone Shetelig FRI409 Childbirth Experiences In Women With Polycystic Ovary Syndrome |
topic_facet |
Reproductive Endocrinology |
description |
Disclosure: A.E. Husby: None. M.R. Simpson: None. R. Dalbye: None. E. Vanky: None. T.S. Løvvik: None. Introduction:Polycystic ovary syndrome (PCOS) affects 5-20% of women. Women with PCOS frequently suffer from metabolic, psychological, and reproductive comorbidities. Pregnancy complications such as gestational diabetes, pregnancy-induced hypertension, pre-eclampsia, and preterm birth are more common in PCOS. Metformin has been used in an attempt to improve pregnancy outcomes in PCOS. Childbirth experience is influenced by previous life- and birth experiences, preparedness, fear of childbirth, experiences of pain and control, and the mode and outcome of delivery. A positive childbirth experience may result in improved post-partum functioning and bonding with the newborn. In contrast, a negative childbirth experience is associated with postnatal depression, post-traumatic stress symptoms and difficulties in relating to one’s partner and newborn. To our knowledge, there are no previous studies on women with PCOS and their childbirth experiences. The primary aim of our study is to explore childbirth experiences in women with PCOS compared to a reference population. The secondary aim is to explore whether metformin vs placebo during pregnancy affects the childbirth experiences in women with PCOS. Materials and methods:This study combines data from two RCTs. In the PregMet2 study, women with PCOS in Norway, Sweden and Iceland were randomized to metformin or placebo. Main outcomes were miscarriage and preterm delivery. The Labor Progression Study (LaPS) (reference population) in Norway, compared WHO partograph to the Zhang’s guidelines for progression of labor in women in Robson group 1*. Both studies used the Childbirth Experience Questionaire (CEQ). Total CEQ scores and scores (separately) from the four domains “own capacity”, “perceived safety”, “professional support” and “participation” were compared between a) women with PCOS in the PregMet2 study (n=131) and the reference population, the LaPS study (n=3604) and ... |
format |
Text |
author |
Husby, Anne Engtrø Simpson, Melanie Rae Dalbye, Rebecka Vanky, Eszter Løvvik, Tone Shetelig |
author_facet |
Husby, Anne Engtrø Simpson, Melanie Rae Dalbye, Rebecka Vanky, Eszter Løvvik, Tone Shetelig |
author_sort |
Husby, Anne Engtrø |
title |
FRI409 Childbirth Experiences In Women With Polycystic Ovary Syndrome |
title_short |
FRI409 Childbirth Experiences In Women With Polycystic Ovary Syndrome |
title_full |
FRI409 Childbirth Experiences In Women With Polycystic Ovary Syndrome |
title_fullStr |
FRI409 Childbirth Experiences In Women With Polycystic Ovary Syndrome |
title_full_unstemmed |
FRI409 Childbirth Experiences In Women With Polycystic Ovary Syndrome |
title_sort |
fri409 childbirth experiences in women with polycystic ovary syndrome |
publisher |
Oxford University Press |
publishDate |
2023 |
url |
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554886/ https://doi.org/10.1210/jendso/bvad114.1602 |
genre |
Iceland |
genre_facet |
Iceland |
op_source |
J Endocr Soc |
op_relation |
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554886/ http://dx.doi.org/10.1210/jendso/bvad114.1602 |
op_rights |
© The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
op_doi |
https://doi.org/10.1210/jendso/bvad114.1602 |
container_title |
Journal of the Endocrine Society |
container_volume |
7 |
container_issue |
Supplement_1 |
_version_ |
1781700668176728064 |